These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6359097)

  • 1. [Effect of heparin and prostacyclin on blood platelet activity].
    Kisiel S; Myśliwiec M; Jakubowska I; Rydzewski A
    Pol Tyg Lek; 1983 Jun; 38(24):717-20. PubMed ID: 6359097
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation.
    Bertelé V; Roncaglioni MC; Donati MB; de Gaetano G
    Thromb Haemost; 1983 Apr; 49(2):81-3. PubMed ID: 6346573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
    Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
    Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of interaction of heparin with ADP and prostacyclin on rat platelets.
    Roncaglioni MC; Bertelé V; de Gaetano G; Donati MB
    Thromb Res; 1983 Jul; 31(2):397-400. PubMed ID: 6356460
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet involvement in the activated coagulation time of heparinized blood.
    Moorehead MT; Westengard JC; Bull BS
    Anesth Analg; 1984 Apr; 63(4):394-8. PubMed ID: 6367544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between prostacyclin analogue ZK 36374 and heparin in their effects upon platelet function.
    Yardumian DA; O'Flynn K; Linch DC; Machin SJ
    Br J Haematol; 1987 Mar; 65(3):325-30. PubMed ID: 2436647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sulphated polysaccharides on prostacyclin (prostaglandin I2)-induced inhibition of platelet aggregation [proceedings].
    Kindness G; Williamson FB; Long WF
    Biochem Soc Trans; 1980 Jun; 8(3):377-9. PubMed ID: 6995209
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreased platelet sensitivity to prostacyclin during hemodialysis: an effect of platelet/heparin interaction?
    Knudsen F; Kristensen SD; Nielsen AH; Ring T; Stoffersen E
    Clin Nephrol; 1985 Feb; 23(2):107. PubMed ID: 3886225
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin neutralization of PGI2: effects upon platelets.
    Saba HI; Saba SR; Blackburn CA; Hartmann RC; Mason RG
    Science; 1979 Aug; 205(4405):499-501. PubMed ID: 377493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic actions of prostacyclin and an isoquinoline derivative (CH-102) on ADP-induced aggregation of dog platelets in vitro.
    Pataricza J; Bor P; Szekeres L
    Biomed Biochim Acta; 1984; 43(12):1365-9. PubMed ID: 6398698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet alterations in shear flow: dose response of prostacyclin on human platelets.
    Hung TC; Butter DB; Graham MF; Lewis JH; Zhao JQ; Haubold AD
    Trans Am Soc Artif Intern Organs; 1983; 29():436-41. PubMed ID: 6424310
    [No Abstract]   [Full Text] [Related]  

  • 12. Release of a prostacyclin-like substance into the circulation of dogs by intravenous adenosine 5'-diphosphate.
    Hemker DP; Shebuski RJ; Aiken JW
    J Pharmacol Exp Ther; 1980 Feb; 212(2):246-52. PubMed ID: 6985960
    [No Abstract]   [Full Text] [Related]  

  • 13. Heparin and dextran sulfate antagonize PGI2 inhibition of platelet aggregation.
    Eldor A; Weksler BB
    Thromb Res; 1979; 16(5-6):617-28. PubMed ID: 392805
    [No Abstract]   [Full Text] [Related]  

  • 14. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
    Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
    Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
    Mardla V; Kobzar G; Samel N
    Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of heparin on platelet reactivity in citrated plasma.
    Beck EA
    Thromb Haemost; 1977 Aug; 38(2):578-80. PubMed ID: 579499
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet inhibitory activity of prostacyclin in the presence of erythrocytes as studied with the impedance aggregometer.
    Gresele P; Deckmyn H; Arnout J; Vermylen J
    Br J Haematol; 1984 May; 57(1):171-3. PubMed ID: 6372851
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
    Ajayi AA; Pharmacols FB; Cooper J; Horn EH; Rubin PC
    Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of heparin on the aggregation function of thrombocytes].
    Zhukovskaia ES; Blindar' VN
    Farmakol Toksikol; 1984; 47(5):36-40. PubMed ID: 6500033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective method for thrombotic diseases using prostaglandin I2.
    Isobe J; Mizuno A
    Tokushima J Exp Med; 1982 Jun; 29(1-2):95-101. PubMed ID: 6755803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.